Repligen (RGEN) Net Income towards Common Stockholders (2010 - 2026)

Repligen's (RGEN) quarterly Net Income towards Common Stockholders came in at $8.4 million in Q1 2026, up 43.6% year-on-year from $5.8 million in Q1 2025, and down 37.17% on a QoQ basis from $13.3 million in Q4 2025.

Repligen (RGEN) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends

Repligen (RGEN) has 17 years of Net Income towards Common Stockholders data on file, last reported at $8.4 million in Q1 2026.

  • On a quarterly basis, Net Income towards Common Stockholders rose 43.6% year-over-year to $8.4 million in Q1 2026; TTM through Mar 2026 was $51.5 million, a 232.93% increase from a year earlier, with the FY2025 full-year figure at $48.9 million, up 218.51% from the prior year.
  • Net Income towards Common Stockholders for Q1 2026 stood at $8.4 million, down from $13.3 million in the prior quarter.
  • Over the last five years, Net Income towards Common Stockholders for RGEN reached as high as $49.9 million in Q2 2022 and fell as low as -$49.6 million in Q4 2024.
  • Historically, Net Income towards Common Stockholders has averaged $16.0 million across 5 years, with a median of $14.9 million in 2025.
  • Across the five-year window, Net Income towards Common Stockholders plunged 1164.41% in 2024 and surged 2380.12% in 2025, its largest moves.
  • Year by year, Net Income towards Common Stockholders stood at $48.7 million in 2022, then tumbled by 90.43% to $4.7 million in 2023, then plunged by 1164.41% to -$49.6 million in 2024, then surged by 126.86% to $13.3 million in 2025, then sank by 37.17% to $8.4 million in 2026.
  • Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were $8.4 million in Q1 2026, $13.3 million in Q4 2025, and $14.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Intuitive Surgical 126.32 Bn 121.10 Bn 1.96 Bn 823.20 Mn
2 Becton Dickinson 44.69 Bn 43.88 Bn 2.15 Bn -274.00 Mn
3 Alcon 32.80 Bn 31.14 Bn 1.53 Bn 22.13 Bn
4 Medline 32.72 Bn 30.49 Bn 1.84 Bn 239.00 Mn
5 Resmed 29.54 Bn 27.88 Bn 890.98 Mn 398.73 Mn
6 West Pharmaceutical Services 23.56 Bn 23.13 Bn 329.20 Mn 147.90 Mn
7 Solventum 14.00 Bn 13.44 Bn 1.10 Bn 13.00 Mn
8 Cooper Companies 13.75 Bn 13.61 Bn 735.40 Mn -77.90 Mn
9 Align Technology 12.03 Bn 10.97 Bn 736.59 Mn 112.77 Mn
10 Repligen 7.37 Bn 6.39 Bn 108.28 Mn 8.37 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 8.37 Mn
Dec 31, 2025 13.32 Mn
Sep 30, 2025 14.91 Mn
Jun 30, 2025 14.87 Mn
Mar 31, 2025 5.83 Mn
Dec 31, 2024 -49.61 Mn
Sep 30, 2024 -654,000.00
Jun 30, 2024 5.71 Mn
Mar 31, 2024 3.30 Mn
Dec 31, 2023 4.66 Mn
Sep 30, 2023 16.92 Mn
Jun 30, 2023 19.79 Mn
Mar 31, 2023 28.83 Mn
Dec 31, 2022 48.73 Mn
Sep 30, 2022 40.41 Mn
Jun 30, 2022 49.86 Mn
Mar 31, 2022 47.35 Mn
Dec 31, 2021 29.11 Mn
Sep 30, 2021 33.50 Mn
Jun 30, 2021 36.23 Mn